Evidence map›Paper›PMID 31105842›Full record

ArticleAmerican journal of translational research2019

Quantitative assessment of human uterine fibroid xenograft using sequential in vivo bioluminescence imaging.

Yihong Pan, Tongqian Xiao, Yuanshuai Zhou, Zhihong Chai, Zhongjuan Xu, Meizhen Dai, Xuejiao Chen, Guangli Suo, Deyou Tao

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yihong PanGynecology of Taizhou Enze Medical Center (Group) Enze Hospital Taizhou, Zhejiang, China.
Tongqian XiaoCAS Key Laboratory of Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences Suzhou, Jiangsu, China.
Yuanshuai ZhouCAS Key Laboratory of Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences Suzhou, Jiangsu, China.
Zhihong ChaiGynecology of Taizhou Municipal Hospital Taizhou, Zhejiang, China.
Zhongjuan XuCAS Key Laboratory of Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences Suzhou, Jiangsu, China.
Meizhen DaiCentral Laboratory of Taizhou Hospital Taizhou, Zhejiang, China.
Xuejiao ChenCentral Laboratory of Taizhou Hospital Taizhou, Zhejiang, China.
Guangli SuoCAS Key Laboratory of Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences Suzhou, Jiangsu, China.
Deyou TaoSurgical Oncology of Taizhou Enze Medical Center (Group) Enze Hospital Taizhou, Zhejiang, China.
Suzhou Institute of Nano-tech and Nano-bionics · CNTaizhou Central Hospital · CNWenzhou Medical University · CNTaizhou Municipal Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uterine fibroid is one of the most common solid tumors occurring in reproductive age women. Lack of accurate methods for

Indexed as

Bioluminescence imaginghuman uterine fibroidin vivo quantitative assessmentxenograft

Identifiers

PMID31105842
PMCPMC6511785
OpenAlexW3009287675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.